Worldwide use of HPV self-sampling for cervical cancer screening

An increasing body of evidence supports the validity of self-sampling as an alternative to clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling effectively reaches underscreened women and can be a powerful strategy in low- and high-resource settings for all target age...

Full description

Saved in:
Bibliographic Details
Published in:Preventive medicine 2022-01, Vol.154, p.106900-106900, Article 106900
Main Authors: Serrano, B., Ibáñez, R., Robles, C., Peremiquel-Trillas, P., de Sanjosé, S., Bruni, L.
Format: Article
Language:English
Subjects:
cervical cancer
COVID-19
Early Detection of Cancer
Female
HPV
Humans
Mass Screening
Papillomaviridae
Papillomavirus Infections - diagnosis
SARS-CoV-2
screening
Self Care
self-sampling
Specimen Handling
Uterine Cervical Neoplasms - diagnosis
Vaginal Smears
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An increasing body of evidence supports the validity of self-sampling as an alternative to clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling effectively reaches underscreened women and can be a powerful strategy in low- and high-resource settings for all target ages. This work aims to summarize the current use of HPV self-sampling worldwide. It is part of a larger project that describes cervical cancer screening programmes and produces standardized coverage estimates worldwide. A systematic review of the literature and official documents supplemented with a formal World Health Organisation country consultation was conducted. Findings show that the global use of HPV self-sampling is still limited. Only 17 (12%) of countries with identified screening programs recommend its use, nine as the primary collection method, and eight to reach underscreened populations. We identified 10 pilots evaluating the switch to self-sampling in well-established screening programs. The global use of self-sampling is likely to increase in the coming years. COVID-19's pandemic has prompted efforts to accelerate HPV self-sampling introduction globally, and it is now considered a key element in scaling up screening coverage. The information generated by the early experiences can be beneficial for decision-making in both new and existing programs.
ISSN:0091-7435
1096-0260
DOI:10.1016/j.ypmed.2021.106900